Cargando…

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment

BACKGROUND: Alendronate (Alen) is promising material used for bone-targeted drug delivery due to its high bone affinity and therapeutic effects on bone diseases. In addition, Alen can enhance the osteogenic differentiation of osteoblastic cell. Recently, nanodiamonds (NDs) with hardness, non-toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Guk Young, Kim, Sung-Eun, Yun, Tae Hoon, Choi, Inseong, Park, Daewon, Choi, Sung-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461989/ https://www.ncbi.nlm.nih.gov/pubmed/34556181 http://dx.doi.org/10.1186/s40824-021-00231-9

Ejemplares similares

Accelerated Osteogenic Differentiation of MC3T3-E1 Cells by Lactoferrin-Conjugated Nanodiamonds through Enhanced Anti-Oxidant and Anti-Inflammatory Effects
por: Kim, Sung Eun, et al.
Publicado: (2019)

Icariin-Functionalized Nanodiamonds to Enhance Osteogenic Capacity In Vitro
por: Choi, Somang, et al.
Publicado: (2020)

Alendronate-Anionic Clay Nanohybrid for Enhanced Osteogenic Proliferation and Differentiation
por: Piao, Huiyan, et al.
Publicado: (2019)

Alendronate-Eluting Biphasic Calcium Phosphate (BCP) Scaffolds Stimulate Osteogenic Differentiation
por: Kim, Sung Eun, et al.
Publicado: (2015)

Fabrication and optimization of Nanodiamonds-composited poly(ε-caprolactone) fibrous matrices for potential regeneration of hard tissues
por: Ahn, Guk Young, et al.
Publicado: (2018)

Multifunctional Tannic Acid-Alendronate Nanocomplexes with Antioxidant, Anti-Inflammatory, and Osteogenic Potency
por: Choi, Somang, et al.
Publicado: (2021)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer
por: Salaam, Amanee D, et al.
Publicado: (2014)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Fluorescent nanodiamond – hyaluronate conjugates for target-specific molecular imaging
por: Han, Hye Hyeon, et al.
Publicado: (2021)

Development of an alginate-gelatin bioink enhancing osteogenic differentiation by gelatin release
por: Kim, Jueun, et al.
Publicado: (2023)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Alendronate Enhances Functional Recovery after Spinal Cord Injury
por: Choi, Yuna, et al.
Publicado: (2022)

Enhanced Osteogenic Differentiation of Human Mesenchymal Stem Cells on Amine-Functionalized Titanium Using Humidified Ammonia Supplied Nonthermal Atmospheric Pressure Plasma
por: Kwon, Jae-Sung, et al.
Publicado: (2020)

Vitamin D-conjugated gold nanoparticles as functional carriers to enhancing osteogenic differentiation
por: Nah, Haram, et al.
Publicado: (2019)

Functionalisation of Detonation Nanodiamond for Monodispersed, Soluble DNA-Nanodiamond Conjugates Using Mixed Silane Bead-Assisted Sonication Disintegration
por: Edgington, Robert, et al.
Publicado: (2018)

Synthesis of Inorganic Pyrophosphatase–Nanodiamond Conjugates Resistant to Calcium and Fluoride
por: Valueva, Anastasiya V., et al.
Publicado: (2020)

Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis
por: Qin, Ling, et al.
Publicado: (2007)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
por: Jain, Sumit Kumar, et al.
Publicado: (2011)

Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report
por: Widjaja, David, et al.
Publicado: (2011)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer
por: Alhakamy, Nabil A., et al.
Publicado: (2021)

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012)

Effect of alendronate on bone remodeling around implant in the rat
por: Park, Ran, et al.
Publicado: (2013)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

PTX3 Effects on Osteogenic Differentiation in Osteoporosis: An In Vitro Study
por: Greggi, Chiara, et al.
Publicado: (2021)

Inhibition of Osteoclast Differentiation and Promotion of Osteogenic Formation by Wolfiporia extensa Mycelium
por: Son, Tae Hyun, et al.
Publicado: (2023)

Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model
por: Muraleva, Natalya A., et al.
Publicado: (2012)

A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Inorganic Pyrophosphatase–Nanodiamond Conjugates Hydrolyze Pyrophosphate in Human Synovial Fluid
por: Valueva, Anastasiya V., et al.
Publicado: (2020)

Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pf15leeegn16ucugbdcji3ndpr